Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darunavir and Cobicistat in COVID-19
NCT04252274Phase 3Unknown
- Start
- Jan 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of darunavir, cobicistat in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
darunavircobicistat
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04252274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04252274.